Sygen Pharmaceuticals Strengthens Industry Leadership and Visibility in 2025
Sygen Pharmaceuticals, one of our portfolio companies, ended the year with strong visibility and established thought leadership within Nigeria’s pharmaceutical sector. In November, Sygen participated in the Pharmaceutical Society of Nigeria’s 98th Annual National Conference in Kano, where it engaged with senior industry stakeholders to share insights, build professional networks, and contribute to discussions shaping the future of pharmaceutical practice in the country.
To further enhance its leadership profile, Sygen’s Chief Executive Officer, Charles Ogunwuyi, was featured on the premiere episode of The Cure Podcast, a new healthcare platform that highlights leaders transforming health systems in Africa. During the discussion, Charles emphasized the importance of developing African-led pharmaceutical solutions that align with local health priorities and foster innovation. His views on reducing import dependence and building resilient, home-grown manufacturing capabilities are closely aligned with
Sygen’s mission and the broader momentum within Africa’s pharmaceutical ecosystem.
At Àrgentil, we are proud to support Sygen’s growing leadership and visibility as it continues to influence critical conversations and create a positive impact across Africa’s healthcare landscape.
